AstraZeneca vaccine currently banned in Denmark, Norway and Iceland

There have been some cases of blood clotting after vaccination. Health officials in Denmark, Norway and Iceland suspended the use of the AstraZeneca vaccine after reports of blood clots forming in some people who were vaccinated.


Health authorities in Denmark, Norway and Iceland have suspended the use of AstraZeneca's Corona vaccine. This step has been taken after reports of blood clotting in some people after vaccination. Austria had earlier banned the use of a batch of AstraZeneca. A 60-year-old woman's blood clot became clogged after being vaccinated in Denmark, leading to her death. He was vaccinated in the same batch, which was being used in Australia.

Denmark has stopped using the vaccine for two weeks after the case came to light. Norway and Iceland have also taken similar steps. Italy has also said that a batch of AstraZeneca's vaccine will be suspended. Meanwhile, the European Medicines Regulatory European Medicine Agency (EMA) says the benefits of the vaccine outweigh the dangers of its use and its use Can be continued.

Some experts believe that it is too early to see some cases of blood clotting with vaccines. There is no evidence of this yet. Over 11 million doses of the AstraZeneca vaccine have been administered throughout the UK so far. The drug regulator of the European Union says that the ratio of blood clotting after the vaccine is almost the same as in the general population. Clotting has been reported in 22 out of 30 lakh vaccinated people. The EMA said that Denmark and Norway have decided to suspend the vaccine as a vigilance.

Despite Denmark's current decision to stop the use of AstraZeneca's Corona vaccine in Norway and Iceland, Mexico has said that it will continue to introduce the Coronavirus vaccine in its home country. 

 

The Brief. Sign up to receive the top stories you need to know right now.